COVID-19 booster vaccine campaign begins in England
Reuters
Published Sep 16, 2021 13:11
LONDON (Reuters) - England launched its COVID-19 booster vaccination campaign on Thursday, the National Health Service (NHS) said, after officials and the government gave the go-ahead for the programme earlier in the week.
British Prime Minister Boris Johnson on Tuesday outlined how the booster programme for over-50s and other priority groups will form a key plank of his plan to navigate the winter without further coronavirus lockdowns.
Booster vaccinations will be given at least six months after people received their second dose of COVID-19 vaccine, meaning the rollout will roughly follow the original priority list, and start with the oldest, most vulnerable and health workers.
NHS England said that hospital hubs had started vaccinating health workers, with full rollout to the community set to begin next week.
"It is brilliant to see that the first booster jabs are being rolled out today," health minister Sajid Javid said.
"I urge everyone who is eligible to come forward for their booster when invited, to prolong the protection that the vaccine offers those most at risk as we approach the winter months."
Britain's Joint Committee on Vaccination and Immunisation (JCVI) recommended that Pfizer/BioNTech's shot be used in the booster campaign, or alternatively a half-dose of Moderna (NASDAQ:MRNA)'s vaccine.
The government also decided this week to move ahead with mass vaccination of children aged 12-15, which the NHS said would begin in schools next week.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.